Literature DB >> 16788801

Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids.

E Levy1, S Spahis, E Ziv, A Marette, M Elchebly, M Lambert, E Delvin.   

Abstract

AIMS/HYPOTHESIS: Emerging evidence underscores the important role of the small intestine in the pathogenesis of dyslipidaemia in insulin resistance and type 2 diabetes. We therefore tested the hypothesis that n-3 fatty acids improve the various events governing intra-enterocyte lipid transport in Psammomys obesus gerbils, a model of nutritionally induced metabolic syndrome.
MATERIALS AND METHODS: Experiments were carried out on Psammomys obesus gerbils that were assigned to an isocaloric control diet and a diet rich in fish oil for 6 weeks.
RESULTS: Increased dietary intake of fish oil lowered body weight and improved hyperglycaemia and hyperinsulinaemia. It simultaneously decreased de novo intestinal lipogenesis and lipid esterification of the major lipid classes, e.g. triglycerides, phospholipids and cholesteryl esters, particularly in insulin-resistant and diabetic animals. Accordingly, lessened activity of monoacylglycerol and diacylglycerol acyltransferase was recorded. As assessed in cultured jejunal explants incubated with either [(14)C]-oleic acid or [(35)S]-methionine, fish oil feeding resulted in diminished triglyceride-rich lipoprotein assembly and apolipoprotein (apo) B-48 biogenesis, respectively. The mechanisms did not involve apo B-48 transcription or alter the gene expression and activity of the critical microsomal triglyceride transfer protein. Rather, the suppressed production of apo B-48 by n-3 fatty acids was associated with intracellular proteasome-mediated posttranslational downregulation in insulin-resistant and diabetic animals. CONCLUSIONS/
INTERPRETATION: Our data highlight the beneficial impact of n-3 fatty acids on adverse effects of the metabolic syndrome and emphasise their influence on intestinal lipid transport, an effect which may limit postprandial lipaemia and the risk of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788801     DOI: 10.1007/s00125-006-0315-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  52 in total

1.  Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine.

Authors:  R A Coleman
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

2.  Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.

Authors:  F Karpe; S Boquist; R Tang; G M Bond; U de Faire; A Hamsten
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

3.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

4.  Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study.

Authors:  J R McNamara; P K Shah; K Nakajima; L A Cupples; P W Wilson; J M Ordovas; E J Schaefer
Journal:  Atherosclerosis       Date:  2001-01       Impact factor: 5.162

Review 5.  Postprandial lipoproteins and atherosclerosis.

Authors:  K C Yu; A D Cooper
Journal:  Front Biosci       Date:  2001-03-01

6.  The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants.

Authors:  E Levy; D Ménard; E Delvin; S Stan; G Mitchell; M Lambert; E Ziv; J C Feoli-Fonseca; E Seidman
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

7.  Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes.

Authors:  Monika Zoltowska; Ehud Ziv; Edgard Delvin; Daniel Sinnett; Ronny Kalman; Carole Garofalo; Ernest Seidman; Emile Levy
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

8.  Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters.

Authors:  Gary F Lewis; Mark Naples; Kristine Uffelman; Nathalie Leung; Linda Szeto; Khosrow Adeli
Journal:  Endocrinology       Date:  2004-07-22       Impact factor: 4.736

9.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

10.  Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.

Authors:  L Axelrod; J Camuso; E Williams; K Kleinman; E Briones; D Schoenfeld
Journal:  Diabetes Care       Date:  1994-01       Impact factor: 19.112

View more
  13 in total

Review 1.  Dyslipidaemia of diabetes and the intestine.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  World J Diabetes       Date:  2015-07-10

2.  Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.

Authors:  Patrick Couture; André J Tremblay; Isabelle Kelly; Valéry Lemelin; Arnaud Droit; Benoît Lamarche
Journal:  J Lipid Res       Date:  2013-10-18       Impact factor: 5.922

3.  Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

Authors:  Esther M M Ooi; Alice H Lichtenstein; John S Millar; Margaret R Diffenderfer; Stefania Lamon-Fava; Helen Rasmussen; Francine K Welty; P Hugh R Barrett; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-07-06       Impact factor: 5.922

4.  Beneficial Effects of Omega-3 Fatty Acids on Low Density Lipoprotein Particle Size in Patients with Type 2 Diabetes Already under Statin Therapy.

Authors:  Myung Won Lee; Jeong Kyung Park; Jae Won Hong; Kwang Joon Kim; Dong Yeob Shin; Chul Woo Ahn; Young Duk Song; Hong Keun Cho; Seok Won Park; Eun Jig Lee
Journal:  Diabetes Metab J       Date:  2013-06-14       Impact factor: 5.376

5.  The chylomicron: relationship to atherosclerosis.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  Int J Vasc Med       Date:  2011-10-05

6.  The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men.

Authors:  Karin M Slivkoff-Clark; Anthony P James; John Cl Mamo
Journal:  Nutr Metab (Lond)       Date:  2012-02-07       Impact factor: 4.169

7.  Altered intestinal functions and increased local inflammation in insulin-resistant obese subjects: a gene-expression profile analysis.

Authors:  Alain Veilleux; Sylvain Mayeur; Jean-Christophe Bérubé; Jean-François Beaulieu; Eric Tremblay; Frédéric-Simon Hould; Yohan Bossé; Denis Richard; Emile Levy
Journal:  BMC Gastroenterol       Date:  2015-09-16       Impact factor: 3.067

Review 8.  Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Authors:  Esther M M Ooi; Gerald F Watts; Theodore W K Ng; P Hugh R Barrett
Journal:  Nutrients       Date:  2015-06-02       Impact factor: 5.717

Review 9.  The UPS in diabetes and obesity.

Authors:  Simon S Wing
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

10.  Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report.

Authors:  Pedro Valdivielso; José Rioja; Carlota García-Arias; Miguel Angel Sánchez-Chaparro; Pedro González-Santos
Journal:  Cardiovasc Diabetol       Date:  2009-01-08       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.